Why This Biotech Fund Increased Its Oruka Stake Amid a 500% Rally
A biotech fund just boosted its Oruka Therapeutics position after a blistering rally. Here’s what the move signals ab...
A quick intro to cash allocations in retirement portfolios. Understanding when to hold cash helps you balance liquidity with growth potential and manage market risk.
22,941 articlesA biotech fund just boosted its Oruka Therapeutics position after a blistering rally. Here’s what the move signals ab...
A blue-chip dividend staple offers resilience in volatile markets. This guide explains why Coca-Cola stands out, how ...
Alphabet’s billion flex is more than just cash. It’s a strategic playbook that powers buybacks, AI investments, and l...
Conagra (CAG) faces a pivotal year as 2026 earnings hinge on pricing, cost control, and portfolio focus. This analysi...
March brings pockets of opportunity for patient buyers. Explore four durable picks that long-term investors should co...
SpaceX stock has shown wild swings since its IPO. This guide offers three dividend stocks to buy that can help you sl...
A quiet demographic trend could reshape the loan landscape by 2031. This article explains what to expect for mortgage...
Geopolitics in the Middle East is testing markets, but Goldman’s international execs Iran say the core financial pict...
With 2026 delivering a 2.8% Social Security COLA, markets and retirees are watching for a potentially larger 2027 inc...
Anthropic’s Claude Code chief says he hasn’t manually coded in about eight months, signaling a broader move to AI-dri...
Markets confront a paradox: AI’s potential is immense, but real-world adoption is uneven. Household budgets and inves...
Celebrity news meets real-world money planning. When Dylan Sprouse Barbara Palvin share that they’re expecting a baby...